Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

8.74
+0.04000.46%
Post-market: 8.740.00000.00%16:10 EDT
Volume:870.74K
Turnover:7.59M
Market Cap:1.59B
PE:-85.68
High:8.80
Open:8.66
Low:8.54
Close:8.70
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.47
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-163.70
PE(LYR):2,725.29

Loading ...

Aug 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 17, 2026

Major Issues Report

Form 8-K - Current report
Jul 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2026

Major Issues Report

Form 8-K - Current report
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Apr 21, 2026

Major Issues Report

Form 8-K - Current report
Mar 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities